• 1. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
• 2. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
• 3. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 4. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 5. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381

Comprehensive Guide to 2-(2,6-dimethylpiperazin-1-yl)ethan-1-amine (CAS No. 468745-67-7): Properties, Applications, and Market Insights

2-(2,6-dimethylpiperazin-1-yl)ethan-1-amine (CAS No. 468745-67-7) is a specialized organic compound that has garnered significant attention in pharmaceutical and chemical research. This piperazine derivative is known for its unique structural features, making it a valuable intermediate in drug discovery and development. With the increasing demand for novel bioactive molecules, compounds like 2-(2,6-dimethylpiperazin-1-yl)ethan-1-amine are becoming crucial in addressing modern therapeutic challenges.

The molecular structure of 2-(2,6-dimethylpiperazin-1-yl)ethan-1-amine includes a piperazine ring substituted with two methyl groups at the 2 and 6 positions, along with an ethylamine side chain. This configuration enhances its versatility in forming stable complexes and interacting with biological targets. Researchers are particularly interested in its potential applications in central nervous system (CNS) drug development, given the rising prevalence of neurological disorders globally.

One of the key advantages of 2-(2,6-dimethylpiperazin-1-yl)ethan-1-amine is its role as a pharmacophore in designing new drugs. Its ability to modulate receptor activity has led to investigations in areas such as antidepressants, antipsychotics, and neuroprotective agents. The compound's lipophilicity and blood-brain barrier permeability make it an attractive candidate for CNS-targeted therapies, a hot topic in current pharmaceutical research.

In addition to its pharmaceutical applications, 2-(2,6-dimethylpiperazin-1-yl)ethan-1-amine is also explored in material science. Its chelating properties are useful in developing advanced polymers and coatings. The compound's stability under various conditions makes it suitable for industrial applications, aligning with the growing interest in sustainable chemistry and green synthesis methods.

The synthesis of 2-(2,6-dimethylpiperazin-1-yl)ethan-1-amine typically involves multi-step organic reactions, including alkylation and amination processes. Recent advancements in catalytic methods have improved the yield and purity of this compound, addressing the need for cost-effective and scalable production. These innovations are particularly relevant in the context of precision medicine and personalized therapeutics, where high-purity intermediates are essential.

Market trends indicate a rising demand for 2-(2,6-dimethylpiperazin-1-yl)ethan-1-amine, driven by the expanding pharmaceutical and biotechnology sectors. Analysts predict steady growth in its applications, especially in neurodegenerative disease research and drug formulation. The compound's compatibility with modern high-throughput screening techniques further enhances its appeal to researchers and manufacturers alike.

Quality control and regulatory compliance are critical when working with 2-(2,6-dimethylpiperazin-1-yl)ethan-1-amine. Reputable suppliers provide detailed certificates of analysis (CoA) and ensure adherence to international standards such as GMP and ISO. These measures are vital for maintaining the integrity of research and industrial applications, particularly in highly regulated fields like pharmaceutical development.

For researchers seeking reliable sources of 2-(2,6-dimethylpiperazin-1-yl)ethan-1-amine, it's essential to consider factors such as purity levels, batch consistency, and supplier reputation. The compound is typically available in various quantities, from milligram-scale for laboratory use to kilogram-scale for industrial applications. Proper storage conditions, including protection from moisture and light, are necessary to maintain its stability over time.

Future research directions for 2-(2,6-dimethylpiperazin-1-yl)ethan-1-amine may explore its potential in combination therapies and targeted drug delivery systems. The compound's structural flexibility allows for modifications that could enhance its bioavailability and therapeutic index. These developments align with current trends in drug discovery, where multi-target approaches are gaining prominence.

In conclusion, 2-(2,6-dimethylpiperazin-1-yl)ethan-1-amine (CAS No. 468745-67-7) represents an important building block in modern chemistry and pharmaceutical research. Its diverse applications, from drug development to material science, coupled with ongoing innovations in synthesis and application, position it as a compound of significant interest. As scientific understanding advances, this piperazine derivative is likely to play an increasingly important role in addressing contemporary health and technological challenges.

• 20327-23-5(1-Cyclopropylpiperazine)
• 25057-77-6(1,2-Dimethylpiperazine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)